ANTIMICROBIAL PHARMACOTHERAPY OF COMMUNITY-ACQUIRED PNEUMONIA IN LIVER CIRRHOSIS PATIENTS: ACCENT ON THE ANTIBIOTIC RESISTANCE RISK STRATIFICATION ArticleKobelevskaya N., Kudryashova Z.Journal of Global Pharma Technology. Vol. 12. 2020. P.. 104-110
